Skip to content
Riskpilot
← Back to search
Sign in
Get full access
MIM PHARMA AS
AS
Active
Org 911618397
Forretning / Produksjonsanlegg Østensjøveien 18, 0661
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2013 · 13 years old
0 employees
www.mimpharma.com
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
MIM PHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JR
Jeanette Ressalehi
Chief Executive Officer
Chief Executive Officer
2022
Former (1)
JW
Jeanette Westby Myhre
Chief Executive Officer
Chief Executive Officer
2022 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
PB
Peter Bahram Ressalehi
Chairman
Chairman
2022
MH
Mona Hedvig Myhre
Board of Directors
Board of Directors
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Saleh Ramazani Khorshiddoust
Company
25%
25%
2025
Reza Ramazani Khorshiddoust
Company
25%
25%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on MIM PHARMA AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network